Non–small‐lung cancer (NSCLC) is the leading cause of cancer death. Early detection of
NSCLC could pave the way for effective therapies. Analysis of molecular genetic biomarkers …

Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related death.
Developing minimally invasive techniques that can diagnose NSCLC, particularly at an early …

Lung cancer (LC) is the leading cause of cancer‑related death, with high incidence and
mortality rate. Early diagnosis and treatment of LC are imperative to improve the 5‑year …

Current clinical diagnostic methods lack the specificity in detecting lung cancer patients. The
issue is particularly critical for stage I and II patients. Considerable evidence showed …

The detection of nonsmall cell lung cancer (NSCLC) at an early stage presents a daunting
challenge due to the lack of a specific noninvasive marker. The discovery of microRNAs …

A diagnosis of lung cancer at its early stages is vital for improving the survival rate of
patients. MicroRNAs (miRNAs), a family of 19-to 25-nucleotide non-coding small RNAs, are …

Analysis of molecular genetic markers in biological fluids has been proposed as a useful
tool for cancer diagnosis. MicroRNAs (miRNAs) are small regulatory RNAs that are …

Lung cancer is a leading cause of cancer death and late diagnosis is one of the most
important reasons for the high mortality rate. Circulating microRNAs (miRNAs) represent …

The aim of this study was to identify differentially-expressed miRNAs in the serum of non-
small cell lung cancer (NSCLC) patients that might be a clinically-useful tool for lung cancer …

Previous studies have reported that the aberrant expression of circulating microRNAs
(miRNAs/miRs) can be used as diagnostic and prognostic markers in non‑small cell lung …